VTE Prevention & Treatment Guidelines

THESE GUIDELINES ARE FOR USE WITHIN THE MAIDSTONE & TUNBRIDGE WELLS NHS TRUST ONLY

Dalteparin Dosing for VTE Prophylaxis & Treatment based on Body Weight and Renal Function, v2.1 (review due March 2025)

Guideline on Thromboprophylaxis in COVID 19 +ve patients (non-ITU), v1.0 (review due Dec 2021)

Guideline for Thromboprophylaxis in COVID 19 +ve patients admitted to ITU or receiving CPAP on the Respiratory Wards, v1.0 (review due Dec 2021)

Guideline for thromboprophylaxis for patients with a bleed or suspected bleed, v3.0 (review due March 2025)

Thromboprophylaxis Summary, v2.0 (review due March 2025)

Summary of VTE Investigation & Management, v2.0 (review due Sept 2025)

VTE prevention policy & procedure, v5.0 March 2021 (review due March 2025)

VTE diagnosis & management in adults policy & procedure, v3.0 Sept 2021 (review due Sept 2025)

Guidelines for anticoagulation in adult patients with active malignancy, v2.0 (review due Feb 2026)

Ambulatory DVT adult pathway, v6.0 (review due Sept 2025)

Ambulatory PE adult pathway v5.0 (review due Sept 2025)

Please note the above hyper-links open the documents directly from the MTW Trust intranet so should be the most up to date versions. They will only open if you are using a Trust computer. Please log-on to a Trust PC if possible to access using the links above. Otherwise some of these guidelines can be accessed below but it is important to note that they may NOT be the most up to date versions.